CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Takeda Pharmaceutical Company Limited - 4502 CFD

4039.05
0.05%
Market Trading Hours* (UTC) Opens on Monday at 00:00

Mon - Fri: 00:00 - 02:30 03:30 - 06:25

  • Summary
  • Historical Data
Trading сonditions
Spread 13.00
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.011661 %
Charges from full value of position ($-2.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011661%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010562 %
Charges from full value of position ($-2.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010562%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 4041.05
Open 4037.95
1-Year Change -7.9%
Day's Range 4016.97 - 4045.94
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 17, 2025 4039.05 -5.10 -0.13% 4044.15 4051.04 4014.97
Jan 16, 2025 4041.05 -35.96 -0.88% 4077.01 4088.30 4036.95
Jan 15, 2025 4095.00 -30.96 -0.75% 4125.96 4144.94 4082.91
Jan 14, 2025 4126.96 -18.98 -0.46% 4145.94 4145.94 4092.89
Jan 10, 2025 4122.97 -25.27 -0.61% 4148.24 4150.84 4111.78
Jan 9, 2025 4157.93 -6.79 -0.16% 4164.72 4177.21 4138.75
Jan 8, 2025 4177.71 -43.16 -1.02% 4220.87 4229.86 4171.71
Jan 7, 2025 4184.91 11.09 0.27% 4173.82 4194.10 4151.04
Jan 6, 2025 4152.94 -23.97 -0.57% 4176.91 4176.91 4132.65
Dec 30, 2024 4169.92 -25.97 -0.62% 4195.89 4195.89 4162.63
Dec 27, 2024 4183.31 37.37 0.90% 4145.94 4202.09 4145.94
Dec 26, 2024 4128.06 11.99 0.29% 4116.07 4130.56 4104.58
Dec 24, 2024 4115.27 3.60 0.09% 4111.67 4129.26 4108.68
Dec 23, 2024 4107.88 7.89 0.19% 4099.99 4113.18 4079.91
Dec 20, 2024 4097.89 10.69 0.26% 4087.20 4115.17 4085.90
Dec 19, 2024 4082.91 36.98 0.91% 4045.93 4096.29 4045.93
Dec 18, 2024 4099.99 18.08 0.44% 4081.91 4105.38 4080.90
Dec 17, 2024 4093.00 -6.99 -0.17% 4099.99 4114.98 4082.90
Dec 16, 2024 4107.98 -18.18 -0.44% 4126.16 4141.05 4101.88
Dec 13, 2024 4121.97 10.99 0.27% 4110.98 4137.95 4095.89

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Takeda Pharmaceutical Company Limited Company profile

About Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Financial summary

BRIEF: For the nine months ended 31 December 2021, Takeda Pharmaceutical Co Ltd revenues increased 11% to Y2.696T. Net income applicable to common stockholders increased 35% to Y241.42B. Revenues reflect Intellectual Property And Service Revenue segment increase from Y69.04B to Y210.55B, Pharmaceutical Business segment increase of 5% to Y2.485T, Northern America segment increase of 9% to Y1.297T, Japan segment increase of 22% to Y530.25B.

Equity composition

FY'94-02 WAS were estimated. FY'04 Name changed from Takeda Chemical Industries, Ltd. to Takeda Pharmaceutical Company Limited. All 1&3Q, WAS were estimated and used as O/S. FY'08 Q3 WAS=O/S. FY'11 Q3 DWAS is estimated.

Industry: Pharmaceuticals (NEC)

4階
日本橋本町二丁目1番1号
CHUO-KU
TOKYO-TO 103-8668
JP

People also watch

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

XRP/USD

3.17 Price
-3.510% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01583

ETH/USD

3,347.58 Price
-3.970% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,441.70 Price
+1.820% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading